Novelstem International CORP

Novelstem International Corp. has appointed Kreit & Chiu CPA LLP as its new independent registered public accounting firm, effective immediately, to audit the fiscal year ending December 31, 2023.

NovelStem International Corp. reported a net loss of $140,816 for the six months ended June 30, 2026, with current liabilities significantly exceeding current assets, highlighting ongoing liquidity concerns.

NovelStem International Corp. reported a significant reduction in liabilities and a net income for the nine months ended September 30, 2025, driven by asset sales and debt restructuring, despite ongoing going concern doubts.

NovelStem International Corp. posted a significant net income in Q2 2025, driven by the settlement of a major litigation funding liability and the disposal of an equity investment, despite ongoing operational challenges and a going concern warning.

NovelStem International Corp. reports a net loss for Q1 2025 and is focused on securing additional funding and monetizing assets to address going concern uncertainties.

NovelStem International Corp. reported a net loss of $3.07 million for the nine months ended September 30, 2024, and faces significant challenges regarding its ability to continue as a going concern.

NovelStem International Corp. reported a net loss of $605,905 for the six months ended June 30, 2024, and faces substantial doubt about its ability to continue as a going concern.

NovelStem International Corp.'s 2024 10-K filing reveals substantial net losses, an impairment of its NewStem investment, and ongoing concerns about its ability to continue as a going concern.

NovelStem International Corp. reported a net loss of $4.2 million for 2023, primarily due to losses from its investment in NewStem and litigation expenses.